Try a new search

Format these results:

Searched for:

person:hayesr03

Total Results:

528


Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

Fernandez-Rozadilla, Ceres; Timofeeva, Maria; Chen, Zhishan; Law, Philip; Thomas, Minta; Schmit, Stephanie; Díez-Obrero, Virginia; Hsu, Li; Fernandez-Tajes, Juan; Palles, Claire; Sherwood, Kitty; Briggs, Sarah; Svinti, Victoria; Donnelly, Kevin; Farrington, Susan; Blackmur, James; Vaughan-Shaw, Peter; Shu, Xiao-Ou; Long, Jirong; Cai, Qiuyin; Guo, Xingyi; Lu, Yingchang; Broderick, Peter; Studd, James; Huyghe, Jeroen; Harrison, Tabitha; Conti, David; Dampier, Christopher; Devall, Mathew; Schumacher, Fredrick; Melas, Marilena; Rennert, Gad; Obón-Santacana, Mireia; Martín-Sánchez, Vicente; Moratalla-Navarro, Ferran; Oh, Jae Hwan; Kim, Jeongseon; Jee, Sun Ha; Jung, Keum Ji; Kweon, Sun-Seog; Shin, Min-Ho; Shin, Aesun; Ahn, Yoon-Ok; Kim, Dong-Hyun; Oze, Isao; Wen, Wanqing; Matsuo, Keitaro; Matsuda, Koichi; Tanikawa, Chizu; Ren, Zefang; Gao, Yu-Tang; Jia, Wei-Hua; Hopper, John; Jenkins, Mark; Win, Aung Ko; Pai, Rish; Figueiredo, Jane; Haile, Robert; Gallinger, Steven; Woods, Michael; Newcomb, Polly; Duggan, David; Cheadle, Jeremy; Kaplan, Richard; Maughan, Timothy; Kerr, Rachel; Kerr, David; Kirac, Iva; Böhm, Jan; Mecklin, Lukka-Pekka; Jousilahti, Pekka; Knekt, Paul; Aaltonen, Lauri; Rissanen, Harri; Pukkala, Eero; Eriksson, Johan; Cajuso, Tatiana; Hänninen, Ulrika; Kondelin, Johanna; Palin, Kimmo; Tanskanen, Tomas; Renkonen-Sinisalo, Laura; Zanke, Brent; Männistö, Satu; Albanes, Demetrius; Weinstein, Stephanie; Ruiz-Narvaez, Edward; Palmer, Julie; Buchanan, Daniel; Platz, Elizabeth; Visvanathan, Kala; Ulrich, Cornelia; Siegel, Erin; Brezina, Stefanie; Gsur, Andrea; Campbell, Peter; Chang-Claude, Jenny; Hoffmeister, Michael; Brenner, Hermann; Slattery, Martha; Potter, John; Tsilidis, Konstantinos; Schulze, Matthias; Gunter, Marc; Murphy, Neil; Castells, Antoni; Castellví-Bel, Sergi; Moreira, Leticia; Arndt, Volker; Shcherbina, Anna; Stern, Mariana; Pardamean, Bens; Bishop, Timothy; Giles, Graham; Southey, Melissa; Idos, Gregory; McDonnell, Kevin; Abu-Ful, Zomoroda; Greenson, Joel; Shulman, Katerina; Lejbkowicz, Flavio; Offit, Kenneth; Su, Yu-Ru; Steinfelder, Robert; Keku, Temitope; van Guelpen, Bethany; Hudson, Thomas; Hampel, Heather; Pearlman, Rachel; Berndt, Sonja; Hayes, Richard; Martinez, Marie Elena; Thomas, Sushma; Corley, Douglas; Pharoah, Paul; Larsson, Susanna; Yen, Yun; Lenz, Heinz-Josef; White, Emily; Li, Li; Doheny, Kimberly; Pugh, Elizabeth; Shelford, Tameka; Chan, Andrew; Cruz-Correa, Marcia; Lindblom, Annika; Hunter, David; Joshi, Amit; Schafmayer, Clemens; Scacheri, Peter; Kundaje, Anshul; Nickerson, Deborah; Schoen, Robert; Hampe, Jochen; Stadler, Zsofia; Vodicka, Pavel; Vodickova, Ludmila; Vymetalkova, Veronika; Papadopoulos, Nickolas; Edlund, Chistopher; Gauderman, William; Thomas, Duncan; Shibata, David; Toland, Amanda; Markowitz, Sanford; Kim, Andre; Chanock, Stephen; van Duijnhoven, Franzel; Feskens, Edith; Sakoda, Lori; Gago-Dominguez, Manuela; Wolk, Alicja; Naccarati, Alessio; Pardini, Barbara; FitzGerald, Liesel; Lee, Soo Chin; Ogino, Shuji; Bien, Stephanie; Kooperberg, Charles; Li, Christopher; Lin, Yi; Prentice, Ross; Qu, Conghui; Bézieau, Stéphane; Tangen, Catherine; Mardis, Elaine; Yamaji, Taiki; Sawada, Norie; Iwasaki, Motoki; Haiman, Christopher; Le Marchand, Loic; Wu, Anna; Qu, Chenxu; McNeil, Caroline; Coetzee, Gerhard; Hayward, Caroline; Deary, Ian; Harris, Sarah; Theodoratou, Evropi; Reid, Stuart; Walker, Marion; Ooi, Li Yin; Moreno, Victor; Casey, Graham; Gruber, Stephen; Tomlinson, Ian; Zheng, Wei; Dunlop, Malcolm; Houlston, Richard; Peters, Ulrike
Colorectal cancer (CRC) is a leading cause of mortality worldwide. We conducted a genome-wide association study meta-analysis of 100,204 CRC cases and 154,587 controls of European and east Asian ancestry, identifying 205 independent risk associations, of which 50 were unreported. We performed integrative genomic, transcriptomic and methylomic analyses across large bowel mucosa and other tissues. Transcriptome- and methylome-wide association studies revealed an additional 53 risk associations. We identified 155 high-confidence effector genes functionally linked to CRC risk, many of which had no previously established role in CRC. These have multiple different functions and specifically indicate that variation in normal colorectal homeostasis, proliferation, cell adhesion, migration, immunity and microbial interactions determines CRC risk. Crosstissue analyses indicated that over a third of effector genes most probably act outside the colonic mucosa. Our findings provide insights into colorectal oncogenesis and highlight potential targets across tissues for new CRC treatment and chemoprevention strategies.
PMID: 36539618
ISSN: 1546-1718
CID: 5394972

Grain, Gluten, and Dietary Fiber Intake Influence Gut Microbial Diversity: Data from the Food and Microbiome Longitudinal Investigation

Um, Caroline Y; Peters, Brandilyn A; Choi, Hee Sun; Oberstein, Paul; Beggs, Dia B; Usyk, Mykhaylo; Wu, Feng; Hayes, Richard B; Gapstur, Susan M; McCullough, Marjorie L; Ahn, Jiyoung
UNLABELLED:< 0.05). These findings suggest that whole grain and dietary fiber are associated with overall gut microbiome structure, largely fiber-fermenting microbiota. Higher refined grain and gluten intakes may be associated with lower microbial diversity. SIGNIFICANCE:Regular consumption of whole grains and dietary fiber was associated with greater abundance of gut bacteria that may lower risk of colorectal cancer. Further research on the association of refined grains and gluten with gut microbial composition is needed to understand their roles in health and disease.
PMCID:10035461
PMID: 36968219
ISSN: 2767-9764
CID: 5594522

Elevated dietary carbohydrate and glycemic intake associate with an altered oral microbial ecosystem in two large U.S. cohorts

Monson, Kelsey R; Peters, Brandilyn A; Usyk, Mykhaylo; Um, Caroline Y; Oberstein, Paul E; McCullough, Marjorie L; Purdue, Mark P; Freedman, Neal D; Hayes, Richard B; Ahn, Jiyoung
The human oral microbiome is associated with chronic diseases including cancer. However, our understanding of its relationship with diet is limited. We assessed the associations between carbohydrate and glycemic index (GI) with oral microbiome composition in 834 non-diabetic subjects from the NCI-PLCO and ACS-CPSII cohorts. The oral microbiome was characterized using 16Sv3-4 rRNA-sequencing from oral mouthwash samples. Daily carbohydrate and GI were assessed from food frequency questionnaires. We used linear regression, permutational MANOVA, and negative binomial Generalized Linear Models (GLM) to test associations of diet with α- and β-diversity and taxon abundance (adjusting for age, sex, cohort, BMI, smoking, caloric intake, and alcohol). A q-value (FDR-adjusted P-value) of <0.05 was considered significant. Oral bacterial α-diversity trended higher in participants in the highest quintiles of carbohydrate intake, with marginally increased richness and Shannon diversity (p-trend=0.06 and 0.07). Greater carbohydrate intake was associated with greater abundance of class Fusobacteriia (q=0.02) and genus Leptotrichia (q=0.01) and with lesser abundance of an Actinomyces OTU (q=4.7E-04). Higher GI was significantly related to greater abundance of genus Gemella (q=0.001). This large, nationwide study provides evidence that diets high in carbohydrates and GI may influence the oral microbiome.
PMCID:9770587
PMID: 36567732
ISSN: 2767-9764
CID: 5592052

Interactions between folate intake and genetic predictors of gene expression levels associated with colorectal cancer risk

Haas, Cameron B; Su, Yu-Ru; Petersen, Paneen; Wang, Xiaoliang; Bien, Stephanie A; Lin, Yi; Albanes, Demetrius; Weinstein, Stephanie J; Jenkins, Mark A; Figueiredo, Jane C; Newcomb, Polly A; Casey, Graham; Le Marchand, Loic; Campbell, Peter T; Moreno, Victor; Potter, John D; Sakoda, Lori C; Slattery, Martha L; Chan, Andrew T; Li, Li; Giles, Graham G; Milne, Roger L; Gruber, Stephen B; Rennert, Gad; Woods, Michael O; Gallinger, Steven J; Berndt, Sonja; Hayes, Richard B; Huang, Wen-Yi; Wolk, Alicja; White, Emily; Nan, Hongmei; Nassir, Rami; Lindor, Noralane M; Lewinger, Juan P; Kim, Andre E; Conti, David; Gauderman, W James; Buchanan, Daniel D; Peters, Ulrike; Hsu, Li
Observational studies have shown higher folate consumption to be associated with lower risk of colorectal cancer (CRC). Understanding whether and how genetic risk factors interact with folate could further elucidate the underlying mechanism. Aggregating functionally relevant genetic variants in set-based variant testing has higher power to detect gene-environment (G × E) interactions and may provide information on the underlying biological pathway. We investigated interactions between folate consumption and predicted gene expression on colorectal cancer risk across the genome. We used variant weights from the PrediXcan models of colon tissue-specific gene expression as a priori variant information for a set-based G × E approach. We harmonized total folate intake (mcg/day) based on dietary intake and supplemental use across cohort and case-control studies and calculated sex and study specific quantiles. Analyses were performed using a mixed effects score tests for interactions between folate and genetically predicted expression of 4839 genes with available genetically predicted expression. We pooled results across 23 studies for a total of 13,498 cases with colorectal tumors and 13,918 controls of European ancestry. We used a false discovery rate of 0.2 to identify genes with suggestive evidence of an interaction. We found suggestive evidence of interaction with folate intake on CRC risk for genes including glutathione S-Transferase Alpha 1 (GSTA1; p = 4.3E-4), Tonsuko Like, DNA Repair Protein (TONSL; p = 4.3E-4), and Aspartylglucosaminidase (AGA: p = 4.5E-4). We identified three genes involved in preventing or repairing DNA damage that may interact with folate consumption to alter CRC risk. Glutathione is an antioxidant, preventing cellular damage and is a downstream metabolite of homocysteine and metabolized by GSTA1. TONSL is part of a complex that functions in the recovery of double strand breaks and AGA plays a role in lysosomal breakdown of glycoprotein.
PMID: 36344807
ISSN: 2045-2322
CID: 5357132

The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer

Peters, Brandilyn A; Pass, Harvey I; Burk, Robert D; Xue, Xiaonan; Goparaju, Chandra; Sollecito, Christopher C; Grassi, Evan; Segal, Leopoldo N; Tsay, Jun-Chieh J; Hayes, Richard B; Ahn, Jiyoung
BACKGROUND:Cancer recurrence after tumor resection in early-stage non-small cell lung cancer (NSCLC) is common, yet difficult to predict. The lung microbiota and systemic immunity may be important modulators of risk for lung cancer recurrence, yet biomarkers from the lung microbiome and peripheral immune environment are understudied. Such markers may hold promise for prediction as well as improved etiologic understanding of lung cancer recurrence. METHODS:In tumor and distant normal lung samples from 46 stage II NSCLC patients with curative resection (39 tumor samples, 41 normal lung samples), we conducted 16S rRNA gene sequencing. We also measured peripheral blood immune gene expression with nanoString®. We examined associations of lung microbiota and peripheral gene expression with recurrence-free survival (RFS) and disease-free survival (DFS) using 500 × 10-fold cross-validated elastic-net penalized Cox regression, and examined predictive accuracy using time-dependent receiver operating characteristic (ROC) curves. RESULTS:Over a median of 4.8 years of follow-up (range 0.2-12.2 years), 43% of patients experienced a recurrence, and 50% died. In normal lung tissue, a higher abundance of classes Bacteroidia and Clostridia, and orders Bacteroidales and Clostridiales, were associated with worse RFS, while a higher abundance of classes Alphaproteobacteria and Betaproteobacteria, and orders Burkholderiales and Neisseriales, were associated with better RFS. In tumor tissue, a higher abundance of orders Actinomycetales and Pseudomonadales were associated with worse DFS. Among these taxa, normal lung Clostridiales and Bacteroidales were also related to worse survival in a previous small pilot study and an additional independent validation cohort. In peripheral blood, higher expression of genes TAP1, TAPBP, CSF2RB, and IFITM2 were associated with better DFS. Analysis of ROC curves revealed that lung microbiome and peripheral gene expression biomarkers provided significant additional recurrence risk discrimination over standard demographic and clinical covariates, with microbiome biomarkers contributing more to short-term (1-year) prediction and gene biomarkers contributing to longer-term (2-5-year) prediction. CONCLUSIONS:We identified compelling biomarkers in under-explored data types, the lung microbiome, and peripheral blood gene expression, which may improve risk prediction of recurrence in early-stage NSCLC patients. These findings will require validation in a larger cohort.
PMCID:9609265
PMID: 36303210
ISSN: 1756-994x
CID: 5358192

Alu retroelement copy number and lung cancer risk in the prospective Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial

Wong, Jason Y Y; Cawthon, Richard; Hu, Wei; Ezennia, Somayina; Gadalla, Shahinaz M; Breeze, Charles; Blechter, Batel; Freedman, Neal D; Huang, Wen-Yi; Hosgood, H Dean; Seow, Wei Jie; Bassig, Bryan A; Rahman, Mohammad; Hayes, Richard B; Rothman, Nathaniel; Lan, Qing
PMID: 35609672
ISSN: 1931-3543
CID: 5247942

Tooth count, untreated caries and mortality in US adults: a population-based cohort study

Liu, Jie; Zong, Xiaoyu; Vogtmann, Emily; Cao, Chao; James, Aimee S; Chan, Andrew T; Rimm, Eric B; Hayes, Richard B; Colditz, Graham A; Michaud, Dominique S; Joshipura, Kaumudi J; Abnet, Christian C; Cao, Yin
BACKGROUND:The link between oral diseases and mortality remains under-explored. We aimed to evaluate the associations between tooth count, untreated caries and risk of all-cause and cause-specific mortality. METHODS:Data on 24 029 adults from the National Health and Nutrition Examination Survey 1988-94/1999-2010, with mortality linkage to the National Death Index to 31 December 2015, were analysed. Baseline total number of permanent teeth and any untreated caries were assessed by trained dental professionals. RESULTS:During up to 27 years of follow-up, 5270 deaths occurred. Fewer permanent teeth were associated with higher all-cause mortality, including heart disease and cancer mortality (all P <0.05 for trend) but not cerebrovascular disease mortality. For every 10 teeth missing, the multivariable-adjusted hazard ratios (HRs) were 1.13 (95% CI: 1.08 to 1.18) for all-cause, 1.16 (95% CI: 1.05, 1.29) for heart disease and 1.19 (95% CI: 1.09, 1.29) for cancer mortality. Untreated caries was associated with increased all-cause (HR: 1.26, 95% CI: 1.15, 1.39) and heart disease mortality (HR: 1.48, 95% CI: 1.17, 1.88) but not cerebrovascular disease/cancer mortality, after adjusting for tooth count, periodontitis and sociodemographic/lifestyle factors. Compared with those without untreated caries and with 25-28 teeth, individuals with untreated caries and 1-16 teeth had a 53% increased risk of all-cause mortality (HR: 1.53, 95% CI: 1.27, 1.85) and 96 % increased risk of heart disease mortality (HR: 1.96, 95% CI: 1.28, 3.01). CONCLUSIONS:In nationally representative cohorts, fewer permanent teeth and untreated caries were associated with all-cause and heart disease mortality. Fewer teeth were also associated with higher cancer mortality.
PMID: 35388877
ISSN: 1464-3685
CID: 5204972

Microbial risk score for capturing microbial characteristics, integrating multi-omics data, and predicting disease risk

Wang, Chan; Segal, Leopoldo N; Hu, Jiyuan; Zhou, Boyan; Hayes, Richard B; Ahn, Jiyoung; Li, Huilin
BACKGROUND:With the rapid accumulation of microbiome-wide association studies, a great amount of microbiome data are available to study the microbiome's role in human disease and advance the microbiome's potential use for disease prediction. However, the unique features of microbiome data hinder its utility for disease prediction. METHODS:Motivated from the polygenic risk score framework, we propose a microbial risk score (MRS) framework to aggregate the complicated microbial profile into a summarized risk score that can be used to measure and predict disease susceptibility. Specifically, the MRS algorithm involves two steps: (1) identifying a sub-community consisting of the signature microbial taxa associated with disease and (2) integrating the identified microbial taxa into a continuous score. The first step is carried out using the existing sophisticated microbial association tests and pruning and thresholding method in the discovery samples. The second step constructs a community-based MRS by calculating alpha diversity on the identified sub-community in the validation samples. Moreover, we propose a multi-omics data integration method by jointly modeling the proposed MRS and other risk scores constructed from other omics data in disease prediction. RESULTS:Through three comprehensive real-data analyses using the NYU Langone Health COVID-19 cohort, the gut microbiome health index (GMHI) multi-study cohort, and a large type 1 diabetes cohort separately, we exhibit and evaluate the utility of the proposed MRS framework for disease prediction and multi-omics data integration. In addition, the disease-specific MRSs for colorectal adenoma, colorectal cancer, Crohn's disease, and rheumatoid arthritis based on the relative abundances of 5, 6, 12, and 6 microbial taxa, respectively, are created and validated using the GMHI multi-study cohort. Especially, Crohn's disease MRS achieves AUCs of 0.88 (0.85-0.91) and 0.86 (0.78-0.95) in the discovery and validation cohorts, respectively. CONCLUSIONS:The proposed MRS framework sheds light on the utility of the microbiome data for disease prediction and multi-omics integration and provides a great potential in understanding the microbiome's role in disease diagnosis and prognosis. Video Abstract.
PMID: 35932029
ISSN: 2049-2618
CID: 5286432

Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study

Archambault, Alexi N; Jeon, Jihyoun; Lin, Yi; Thomas, Minta; Harrison, Tabitha A; Bishop, D Timothy; Brenner, Hermann; Casey, Graham; Chan, Andrew T; Chang-Claude, Jenny; Figueiredo, Jane C; Gallinger, Steven; Gruber, Stephen B; Gunter, Marc J; Guo, Feng; Hoffmeister, Michael; Jenkins, Mark A; Keku, Temitope O; Le Marchand, Loïc; Li, Li; Moreno, Victor; Newcomb, Polly A; Pai, Rish; Parfrey, Patrick S; Rennert, Gad; Sakoda, Lori C; Lee, Jeffrey K; Slattery, Martha L; Song, Mingyang; Ko Win, Aung; Woods, Michael O; Murphy, Neil; Campbell, Peter T; Su, Yu-Ru; Lansdorp-Vogelaar, Iris; Peterse, Elisabeth Fp; Cao, Yin; Zeleniuch-Jacquotte, Anne; Liang, Peter S; Du, Mengmeng; Corley, Douglas A; Hsu, Li; Peters, Ulrike; Hayes, Richard B
BACKGROUND:Incidence of colorectal cancer (CRC) among individuals aged less than 50 years has been increasing. As screening guidelines lower the recommended age of screening initiation, concerns including the burden on screening capacity and costs have been recognized, suggesting that an individualized approach may be warranted. We developed risk prediction models for early-onset CRC that incorporate an environmental risk score (ERS), including 16 lifestyle and environmental factors, and a polygenic risk score (PRS), of 141 variants. METHODS:Relying on risk score weights for ERS and PRS derived from studies of CRC at all ages, we evaluated risks for early-onset CRC in 3,486 cases and 3,890 controls aged less than 50 years. Relative and absolute risks for early-onset CRC were assessed according to values of the ERS and PRS. The discriminatory performance of these scores was estimated using the covariate-adjusted area under the receiver operating characteristic curve. RESULTS:Increasing values of ERS and PRS were associated with increasing relative risks for early-onset CRC (odds ratio per standard deviation of ERS = 1.14, 95% confidence interval [CI] = 1.08, 1.20; odds ratio per standard deviation of PRS = 1.59, 95% CI = 1.51, 1.68), both contributing to case-control discrimination (area under the curve = 0.631, 95% CI = 0.615, 0.647). Based on absolute risks, we can expect 26 excess cases per 10,000 men and 21 per 10,000 women, among those scoring at the 90th percentile for both risk scores. CONCLUSIONS:Personal risk scores have the potential to identify individuals at differential relative and absolute risk for early-onset CRC. Improved discrimination may aid in targeted CRC screening of younger, high-risk individuals, potentially improving outcomes.
PMID: 35026030
ISSN: 1460-2105
CID: 5118962

Benzene exposure and risk of benzene poisoning in Chinese workers

Vermeulen, Roel; Portengen, Lützen; Li, Guilan; Gilbert, Ethel S; Dores, Graça M; Ji, Bu-Tian; Hayes, Richard; Yin, Sognian; Rothman, Nathaniel; Linet, Martha S; Lan, Qing
OBJECTIVES/OBJECTIVE:Benzene is a known haematoxin and leukemogen that can cause benzene poisoning (BP), that is, a persistent reduction in white cell counts that is strongly associated with increased risk of lymphohaematopoietic malignancies. Data are needed on the exposure-response, particularly at low doses and susceptible populations for clinical and regulatory purposes. METHODS:In a case-cohort study among 110 631 Chinese workers first employed 1949-1987 and followed up during 1972-1999, we evaluated BP risk according to benzene exposure level and investigated risk modification by subject (sex, attained age) and exposure-related factors (latency, exposure windows, age at first benzene exposure, coexposure to toluene) using excess relative risk and excess absolute risk models. RESULTS:There were 538 BP cases and 909 benzene-exposed referents. The exposure metric with best model fit was cumulative benzene exposure during a 5-year risk window, followed by a 9-month lag period before BP diagnosis. Estimated excess absolute risk of BP at age 60 increased from 0.5% for subjects in the lowest benzene exposure category (>0 to 10 ppm-years) to 5.0% for those in the highest category (>100 ppm-years) compared with unexposed subjects. Increased risks were apparent at low cumulative exposure levels and for workers who were first exposed at <30 years of age. CONCLUSIONS:Our data show a clear association between benzene exposure and BP, beginning at low cumulative benzene exposure levels with no threshold, and with higher risks for workers exposed at younger ages. These findings are important because BP has been linked to a strongly increased development of lymphohaematopoietic malignancies.
PMID: 35273074
ISSN: 1470-7926
CID: 5394042